Unnamed: 0,ID,Description,GeneRatio,BgRatio,pvalue,p.adjust,qvalue,geneID,Count
GO:0042483,GO:0042483,negative regulation of odontogenesis,1/3,2/18800,0.00031913195926,0.0105313546555811,0.0013437135126738,TNFRSF11B,1
GO:0042489,GO:0042489,negative regulation of odontogenesis of dentin-containing tooth,1/3,2/18800,0.00031913195926,0.0105313546555811,0.0013437135126738,TNFRSF11B,1
GO:0110111,GO:0110111,negative regulation of animal organ morphogenesis,1/3,2/18800,0.00031913195926,0.0105313546555811,0.0013437135126738,TNFRSF11B,1
GO:0060400,GO:0060400,negative regulation of growth hormone receptor signaling pathway,1/3,3/18800,0.0004786724744274,0.0118471437420795,0.0015115972876656,GDF15,1
GO:0002023,GO:0002023,reduction of food intake in response to dietary excess,1/3,6/18800,0.0009571921729191,0.0157936708531655,0.0020151414166718,GDF15,1
GO:0035860,GO:0035860,glial cell-derived neurotrophic factor receptor signaling pathway,1/3,10/18800,0.0015949808282637,0.017195899516125,0.0021940541647368,GDF15,1
GO:0040015,GO:0040015,negative regulation of multicellular organism growth,1/3,11/18800,0.0017543855678866,0.017195899516125,0.0021940541647368,GDF15,1
GO:0009991,GO:0009991,response to extracellular stimulus,2/3,479/18800,0.0019106555017916,0.017195899516125,0.0021940541647368,GDF15/TNFRSF11B,2
GO:0045779,GO:0045779,negative regulation of bone resorption,1/3,16/18800,0.0025511547658783,0.0175261267619748,0.0022361884225805,TNFRSF11B,1
GO:1901741,GO:1901741,positive regulation of myoblast fusion,1/3,16/18800,0.0025511547658783,0.0175261267619748,0.0022361884225805,GDF15,1
GO:0032026,GO:0032026,response to magnesium ion,1/3,18/18800,0.0028697436952089,0.0175261267619748,0.0022361884225805,TNFRSF11B,1
GO:0046851,GO:0046851,negative regulation of bone remodeling,1/3,18/18800,0.0028697436952089,0.0175261267619748,0.0022361884225805,TNFRSF11B,1
GO:1901739,GO:1901739,regulation of myoblast fusion,1/3,21/18800,0.0033474998797843,0.0175261267619748,0.0022361884225805,GDF15,1
GO:0034104,GO:0034104,negative regulation of tissue remodeling,1/3,22/18800,0.0035067180224097,0.0175261267619748,0.0022361884225805,TNFRSF11B,1
GO:0060143,GO:0060143,positive regulation of syncytium formation by plasma membrane fusion,1/3,24/18800,0.0038251034347294,0.0175261267619748,0.0022361884225805,GDF15,1
GO:1902993,GO:1902993,positive regulation of amyloid precursor protein catabolic process,1/3,25/18800,0.0039842707062299,0.0175261267619748,0.0022361884225805,SPON1,1
GO:0010954,GO:0010954,positive regulation of protein processing,1/3,26/18800,0.0041434210224953,0.0175261267619748,0.0022361884225805,SPON1,1
GO:1903319,GO:1903319,positive regulation of protein maturation,1/3,28/18800,0.0044616707929325,0.0175261267619748,0.0022361884225805,SPON1,1
GO:1902430,GO:1902430,negative regulation of amyloid-beta formation,1/3,29/18800,0.0046207702489106,0.0175261267619748,0.0022361884225805,SPON1,1
GO:0060142,GO:0060142,regulation of syncytium formation by plasma membrane fusion,1/3,30/18800,0.0047798527532658,0.0175261267619748,0.0022361884225805,GDF15,1
GO:0046685,GO:0046685,response to arsenic-containing substance,1/3,33/18800,0.0052569985656261,0.0179463054481719,0.0022897997382037,TNFRSF11B,1
GO:0060416,GO:0060416,response to growth hormone,1/3,38/18800,0.0060519026380615,0.0198345944911858,0.0025307297596409,GDF15,1
GO:0042755,GO:0042755,eating behavior,1/3,39/18800,0.0062108326184521,0.0198345944911858,0.0025307297596409,GDF15,1
GO:0010862,GO:0010862,positive regulation of pathway-restricted SMAD protein phosphorylation,1/3,49/18800,0.0077992007288346,0.0214086226644474,0.0027315627004079,GDF15,1
GO:0034205,GO:0034205,amyloid-beta formation,1/3,56/18800,0.0089100508055254,0.0214086226644474,0.0027315627004079,SPON1,1
GO:0140253,GO:0140253,cell-cell fusion,1/3,59/18800,0.0093858754831818,0.0214086226644474,0.0027315627004079,GDF15,1
GO:0060393,GO:0060393,regulation of pathway-restricted SMAD protein phosphorylation,1/3,62/18800,0.0098615478400758,0.0214086226644474,0.0027315627004079,GDF15,1
GO:0006949,GO:0006949,syncytium formation,1/3,63/18800,0.0100200714475301,0.0214086226644474,0.0027315627004079,GDF15,1
GO:0050435,GO:0050435,amyloid-beta metabolic process,1/3,66/18800,0.0104955407480055,0.0214086226644474,0.0027315627004079,SPON1,1
GO:0060389,GO:0060389,pathway-restricted SMAD protein phosphorylation,1/3,66/18800,0.0104955407480055,0.0214086226644474,0.0027315627004079,GDF15,1
GO:0042987,GO:0042987,amyloid precursor protein catabolic process,1/3,68/18800,0.0108124356891148,0.0214086226644474,0.0027315627004079,SPON1,1
GO:0043627,GO:0043627,response to estrogen,1/3,68/18800,0.0108124356891148,0.0214086226644474,0.0027315627004079,TNFRSF11B,1
GO:0032092,GO:0032092,positive regulation of protein binding,1/3,83/18800,0.0131869914052786,0.0251060028677419,0.0032033177502701,SPON1,1
GO:0060395,GO:0060395,SMAD protein signal transduction,1/3,83/18800,0.0131869914052786,0.0251060028677419,0.0032033177502701,GDF15,1
GO:0046849,GO:0046849,bone remodeling,1/3,88/18800,0.0139776646841043,0.0256257185875246,0.0032696291658723,TNFRSF11B,1
GO:0051897,GO:0051897,positive regulation of protein kinase B signaling,1/3,119/18800,0.018870414107417,0.0313928110132458,0.0040054623302386,GDF15,1
GO:0090100,GO:0090100,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway,1/3,120/18800,0.0190279746640082,0.0313928110132458,0.0040054623302386,GDF15,1
GO:0014902,GO:0014902,myotube differentiation,1/3,122/18800,0.0193430451697777,0.0313928110132458,0.0040054623302386,GDF15,1
GO:0035264,GO:0035264,multicellular organism growth,1/3,143/18800,0.0226472133284683,0.0350324081174744,0.0044698447358819,GDF15,1
GO:0030509,GO:0030509,BMP signaling pathway,1/3,162/18800,0.0256302960832142,0.0384454441248213,0.0049053198245386,GDF15,1
GO:0071772,GO:0071772,response to BMP,1/3,173/18800,0.0273545663977564,0.0389087216058019,0.004964430188938,GDF15,1
GO:0043393,GO:0043393,regulation of protein binding,1/3,196/18800,0.0309532830510281,0.0425607641951636,0.005430400535268,SPON1,1
